These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26955093)

  • 1. Proposing Melasma Severity Index: A New, More Practical, Office-based Scoring System for Assessing the Severity of Melasma.
    Majid I; Haq I; Imran S; Keen A; Aziz K; Arif T
    Indian J Dermatol; 2016; 61(1):39-44. PubMed ID: 26955093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method.
    Pandya AG; Hynan LS; Bhore R; Riley FC; Guevara IL; Grimes P; Nordlund JJ; Rendon M; Taylor S; Gottschalk RW; Agim NG; Ortonne JP
    J Am Acad Dermatol; 2011 Jan; 64(1):78-83, 83.e1-2. PubMed ID: 20398960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability, Validity, and Sensitivity to Change Overtime of the Modified Melasma Area and Severity Index Score.
    Abou-Taleb DA; Ibrahim AK; Youssef EM; Moubasher AE
    Dermatol Surg; 2017 Feb; 43(2):210-217. PubMed ID: 27930379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with quality of life in facial melasma: a cross-sectional study.
    Pollo CF; Miot LDB; Meneguin S; Miot HA
    Int J Cosmet Sci; 2018 May; ():. PubMed ID: 29734511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salicylic acid for the treatment of melasma: new acquisitions for monitoring the clinical improvement.
    Fabbrocini G; De Vita V; Marasca C; Palmisano F; Monfrecola G
    Skin Res Technol; 2013 Nov; 19(4):466-73. PubMed ID: 23527534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is There a Correlation between Severity of Melasma and Quality of Life?
    Jusuf NK; Putra IB; Mahdalena M
    Open Access Maced J Med Sci; 2019 Aug; 7(16):2615-2618. PubMed ID: 31777617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Efficacy and Safety on Combining 20% Trichloroacetic Acid Peel with Topical 5% Ascorbic Acid for Melasma.
    Dayal S; Sahu P; Yadav M; Jain VK
    J Clin Diagn Res; 2017 Sep; 11(9):WC08-WC11. PubMed ID: 29207818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and Melasma Quality of Life Index in melasma.
    Sarkar R; Ghunawat S; Narang I; Verma S; Garg VK; Dua R
    J Cosmet Dermatol; 2019 Aug; 18(4):1066-1073. PubMed ID: 31033184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between Glutathione Plasma with Degree Severity of Melasma in Balinese Women.
    Wiraguna AAGP; Hari ED; Praharsini IGAA
    Clin Cosmet Investig Dermatol; 2020; 13():455-459. PubMed ID: 32765038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of melasma on quality of life in a sample of women living in southern Brazil.
    Freitag FM; Cestari TF; Leopoldo LR; Paludo P; Boza JC
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):655-62. PubMed ID: 18410339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
    Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
    Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-rich plasma is a useful therapeutic option in melasma.
    Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
    J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
    [No Abstract]   [Full Text] [Related]  

  • 15. Pilot study of an automated method to determine Melasma Area and Severity Index.
    Tay EY; Gan EY; Tan VWD; Lin Z; Liang Y; Lin F; Wee S; Thng TG
    Br J Dermatol; 2015 Jun; 172(6):1535-1540. PubMed ID: 25641313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of 25% L-ascorbic acid (C'ensil) in the treatment of melasma.
    Hwang SW; Oh DJ; Lee D; Kim JW; Park SW
    J Cutan Med Surg; 2009; 13(2):74-81. PubMed ID: 19298775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
    Sarkar R; Garg V; Bansal S; Sethi S; Gupta C
    Dermatol Surg; 2016 Mar; 42(3):384-91. PubMed ID: 26859648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind controlled study of a nonhydroquinone bleaching cream in the treatment of melasma.
    Levy JL; Pons F; Agopian L; Besson R
    J Cosmet Dermatol; 2005 Dec; 4(4):272-6. PubMed ID: 17168876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycolic Acid peels/azelaic Acid 20% cream combination and low potency triple combination lead to similar reduction in melasma severity in ethnic skin: results of a randomized controlled study.
    Mahajan R; Kanwar AJ; Parsad D; Kumaran MS; Sharma R
    Indian J Dermatol; 2015; 60(2):147-52. PubMed ID: 25814702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.